Jack Goldstein Ph.D.
Jack Goldstein, Ph.D., has served as a member of our Board of Directors since May 2010. Dr. Goldstein is currently an independent consultant. He served as President and Chief Operating Officer of Chiron Corporation from 2004 until its acquisition by Novartis in 2006, and from 2002 to 2004 he served as President of Chiron’s Blood Testing Division. From 2000 to 2002, he was a general partner at Windamere Venture Partners. From 1997 to 2001, he served as President and Chief Executive Officer at Applied Imaging Corporation, and from 1999 until 2002, he also served as Chairman of the Board of Applied Imaging. From 1986 to 1997, Dr. Goldstein served in various executive positions at Johnson & Johnson, including President of Ortho Diagnostic Systems and Executive Vice President of Professional Diagnostics. Dr. Goldstein previously served as Chairman of the Board of Directors of OncoGenex Pharmaceuticals, Inc., from March 2010 to August 2017. Dr. Goldstein holds a Bachelor of Arts degree in biology from Rider University and a Master of Science degree in immunology and a Ph.D. in microbiology from St. John’s University.
Class II Director, Term Expires 2020